Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) was up 4.8% during trading on Wednesday. The stock traded as high as $1.09 and last traded at $1.09. Approximately 275 shares were traded during trading, a decline of 90% from the average daily volume of 2,638 shares. The stock had previously closed at $1.04.
Ascletis Pharma Stock Performance
The business’s 50-day simple moving average is $1.21 and its two-hundred day simple moving average is $1.53.
Ascletis Pharma Company Profile
Ascletis Pharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines. The company has historically concentrated on areas of significant unmet medical need, including viral diseases, oncology and metabolic disorders, with operations and commercial activities centered primarily in China.
Ascletis’ portfolio has included therapies for infectious diseases and viral hepatitis. Its best-known product is Ganovo (danoprevir), a hepatitis C treatment developed for use in combination with other antiviral medicines and approved in China.
Recommended Stories
- Five stocks we like better than Ascletis Pharma
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
